Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.5 (
5'-nucleotidase
)
3,167
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The present study investigated plasma activity of
5'-nucleotidase
, a key enzyme in the production of adenosine, in
pre-eclampsia
, and evaluated the relationship between changes in
5'-nucleotidase
activity, and levels of uric acid, endproduct of the purine metabolism, and the severity of
pre-eclampsia
. We measured plasma
5'-nucleotidase
activities and uric acid levels in women with 18 normal pregnancies, mild and severe
pre-eclampsia
. In mild and severe
pre-eclampsia
, plasma
5'-nucleotidase
activities and uric acid levels were significantly increased compared with those in normal pregnancy (p < 0.05). Plasma
5'-nucleotidase
activity increased according to increases in uric acid levels and the severity of
pre-eclampsia
. These results suggest that increased plasma
5'-nucleotidase
activity may, at least in part, be related to changes in purine metabolism in
pre-eclampsia
.
...
PMID:Plasma 5'-nucleotidase activities and uric acid levels in women with pre-eclampsia. 1257 40
Background AMP-deaminase (EC 3.5.4.6) and
5'-nucleotidase
(
EC 3.1.3.5
) are enzymes responsible for the maintenance of cellular adenine nucleotides pool. Both exist in several isoforms that differ in kinetic properties and tissue distribution. Profile of isoforms of these enzymes in human placenta has not been analyzed so far while this could be important for understanding of pathology of placental ischemia such as in
preeclampsia
. Our aim was therefore to analyze expression of AMPD and CN-I genes in human term placenta. Methods RT-PCR analysis was used for determine expression of AMPD1, AMPD2, AMPD3 and CN-I. Results and conclusion The experimental results presented here indicate that genes coding "AMP-preferring", cytosolic isozyme of
5'-nucleotidase
(cN-I) as well as "muscle-type" isozyme of AMP-deaminase (AMPD1) are not expressed in human term placenta. Among other AMPD family genes, only these coding "liver-type" isozyme (AMPD2) and, in lesser degree, "erythrocyte-type" isozyme (AMPD3) of AMP-deaminase are expressed in this organ. The expression level of AMPD3 was a half of that presented by AMPD2. We conclude that high abundance of AMP-deaminase 2 transcript suggest that this particular isoform is a predominant pathway of adenine nucleotides degradation in human term placenta that follows liver-type regulation of this process.
...
PMID:Expression patterns of AMP-deaminase and cytosolic 5'-nucleotidase genes in human term placenta. 1816 23